Varian and Ping An Sign Memorandum of Understanding to Expand Access to High Quality Cancer Care in China | Varian

Varian and Ping An Sign Memorandum of Understanding to Expand Access to High Quality Cancer Care in China

PALO ALTO, Calif. and BEIJING, Jan. 8, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has signed a Memorandum of Understanding (MoU) with Ping An Health Technology Co., Ltd, to explore a strategic partnership for expanding access to cancer care in China. Leveraging their respective technical and domain expertise, the two companies will investigate the utilization of artificial intelligence, cloud computing and big data technologies, to deliver high quality and cost-effective cancer care to a far greater number of people in China, and close to where they live.

Varian and Ping An share a common vision of improving the digitalization and understanding of the entire cancer life cycle, covering prevention, detection, diagnosis, treatment, rehabilitation and palliation. Through their combined efforts, Varian and Ping An will look to create a more comprehensive tool to help healthcare professionals increase the effectiveness of treatment methods such as surgery, chemotherapy, molecular medicine and radiation therapy.

"We are pleased to be collaborating with Ping An, the leading force in the field of healthcare in China, on ways to expand the access to high-quality and cost-effective cancer care in China," said Kevin O'Reilly, president of Asia Pacific for Varian. "By leveraging Varian's advanced technologies and solutions in care management and treatment and Ping An's infrastructure and market reach, together we have the potential to enable a higher level of care for cancer patients in China."

"The cooperation with Varian is a significant milestone for Ping An Health Technology, which expands the development of Ping An Medical and Health in the field of radiation oncology technology," said Mao Biao, director of the Strategic Development Center of Ping An Group. "We look forward to this partnership and how the two companies can collaborate in the fight against cancer."

About Varian
Varian focuses energy on saving lives and is the world's leading manufacturer of medical devices and software for treating and managing cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,500 people around the world. For more information, visit and follow @VarianMedSys on Twitter.

About Ping An
After 30 years of development, Ping An has established a double-drive development model of "Finance + Technology", focusing on the financial industry and the healthcare industry. It's providing integrated financial and healthcare services for 430 million Internet users and 153 million clients. In order to further improve the medical and healthcare ecosystem, Ping An recently established the Ping An Health Technology Co., Ltd. and the Ping'an Medical Technology Research Institute that focuses on R&D of medical technology and product incubation. Meanwhile, Ping An will bring together top researchers in artificial intelligence and cloud computing, to research artificial intelligence as well as the application of technological innovation through the integration of resources in the field of medical science and technology of Ping An Group.

Press Contact

Mark Plungy
Director, Public Relations
+1 (650) 424-5630

Helen Yang
China Manager, Public Relations
+86 (10) 87836354

Investor Relations Contact

J. Michael Bruff
Vice President, Investor Relations
+1 (650) 424-5163